Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

EC approves AstraZeneca and Merck’s Lynparza for two cancer types

pharmaceutical-technologyNovember 06, 2020

Tag: EC , AstraZeneca , Merck , Lynparza , cancer

PharmaSources Customer Service